Evidence map›Paper›PMID 32102478›Full record

ArticlePolymers2020

Gelatin Methacryloyl Hydrogels Control the Localized Delivery of Albumin-Bound Paclitaxel.

Margaux Vigata, Christoph Meinert, Stephen Pahoff, Nathalie Bock, Dietmar W Hutmacher

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. TiONanomaterials (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Dynamic Hydrogels in Breast Tumor Models.Gels (Basel, Switzerland) · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Margaux VigataInstitute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Kelvin Grove QLD 4059, Australia.ORCID 0000-0003-3956-9598
Christoph MeinertInstitute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Kelvin Grove QLD 4059, Australia.ORCID 0000-0002-7036-4067
Stephen PahoffInstitute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Kelvin Grove QLD 4059, Australia.
Nathalie BockInstitute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Kelvin Grove QLD 4059, Australia.
Dietmar W HutmacherInstitute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Kelvin Grove QLD 4059, Australia.ORCID 0000-0001-5678-2134
Queensland University of Technology · AUAustralian Research Council · AUTranslational Research Institute · AU

Funding

Australian Research Council IC160100026Lush 2017-YR-RoW-9National Health and Medical Research Council APP1091734
6 · The paper itself

Abstract

Hydrogels are excellent candidates for the sustained local delivery of anticancer drugs, as they possess tunable physicochemical characteristics that enable to control drug release kinetics and potentially tackle the problem of systemic side effects in traditional chemotherapeutic delivery. Yet, current systems often involve complicated manufacturing or covalent bonding processes that are not compatible with regulatory or market reality. Here, we developed a novel gelatin methacryloyl (GelMA)-based drug delivery system (GelMA-DDS) for the sustained local delivery of paclitaxel-based Abraxane

Indexed as

Abraxane®, controlled releasebreast cancerdrug deliverygelatin methacryloyl hydrogellocalized adjuvant chemotherapy

Identifiers

PMID32102478
PMCPMC7077643
OpenAlexW3007607741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.